Inhibition of formin like 2 promotes the transition of ectopic endometrial stromal cells to epithelial cells in adenomyosis through a MET-like process

You Li, Quan Zhang, Faying Liu, Ziyu Zhang, Yang Zou, Bicheng Yang, Yong Luo, Liqun Wang, Ouping Huang
Gene · 2019 · vol. 710 , pp. 186–192 · doi:10.1016/j.gene.2019.06.003 · PMID:31175924 · W2950393572
article OA: closed CC0 ⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated how inhibiting formin like 2 impacts ectopic endometrial stromal cells in adenomyosis, finding it promotes their transition into epithelial cells via a MET-like process.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Epithelial Cells Proteins Stromal Cells Up-Regulation Adenomyosis Adenomyosis Adult Antigens, CD Antigens, CD Cadherins Cadherins Cell Movement Cell Proliferation Cells, Cultured Epithelial Cells Epithelial Cells Epithelial-Mesenchymal Transition Female Formins

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

Cited by (7)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:48.502547+00:00
License: CC0 · commercial use OK